Objectives

Biohit is a global company operating in two business areas: liquid handling and diagnostics. The company is developing both its business areas as separate units with a view to growing into a profitable and leading global supplier in both areas.

Bolstering the company’s market position in liquid handling
 Biohit already holds a strong position in the liquid handling markets of many geographical regions. The company aims to increase its market share in North America and Asia in particular. Other major goals include cost-effective growth at a rate faster than the market average, as well as bolstering the company’s market position in both existing and new market segments.

The company’s main strategic choices in the liquid handling business are:
•  Customer-oriented operations in all sub-categories.
•  Continual investments in product development and innovations in market segments
   with growth potential.
•  A focus on certified liquid handling solutions that generate added value for customers.
•  Lifecycle management of high-quality, traceable, safe and environmentally
   friendly products.
•  Continual improvements to the cost-effectiveness of logistics and production processes.
•  Increased outlays on marketing and distribution channel development.
•  Growing the company’s maintenance business in main market areas.

Safeguarding profitable growth in the diagnostics business
 The primary goal of the diagnostics business is to safeguard profitable growth. The company seeks net sales growth and product authorisations from the relevant authorities in North America and Asia in particular. This business area stands on the threshold of growth, and therefore requires both substantial financial and personnel resources as well as effective international marketing. This is why an ongoing analysis is investigating the possibility of spinning off the diagnostics business into a separate company and acquiring globally operating partners.

The company’s main strategic choices in the diagnostics business are:
•  Stepping up marketing as new markets open up simultaneously in many countries.
•  Establishing a distribution network specialised in diagnostics.
•  Obtaining authorisations from the relevant authorities as rapidly as possible.
•  The introduction of examinations into public sector healthcare screening
   programmes and reimbursement systems.
•  Continued and expanded collaboration with opinion leaders.
•  Continual investments in research, innovations and product development.